Dt. Dudley et al., A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(17), 1995, pp. 7686-7689
Treatment of cells with a variety of growth factors triggers a phospho
rylation cascade that leads to activation of mitogen-activated protein
kinases (MAPKs, also called extracellular signal-regulated kinases, o
r ERKs). We have identified a synthetic inhibitor of the MAPK pathway.
PD 098059 2-(2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one] selectiv
ely inhibited the MAPK-activating enzyme, MAPK/ERK kinase (MEK), witho
ut significant inhibitory activity of MAPK itself. Inhibition of MEK b
y PD 098059 prevented activation of MAPK and subsequent phosphorylatio
n of MAPK substrates both in vitro and in intact cells. Moreover, PD 0
98059 inhibited stimulation of cell growth and reversed the phenotype
of ras-transformed BALB 3T3 mouse fibroblasts and rat kidney cells. Th
ese results indicate that the MAPK pathway is essential for growth and
maintenance of the ras-transformed phenotype. Further, PD 098059 is a
n invaluable tool that will help elucidate the role of the MAPK cascad
e in a variety of biological settings.